Effective August 9, 2020, the United States Department of Defense awarded MODERNATX INC. a contract for the large-scale production of up to 500 million doses of Moderna’s mRNA-1273, at 100 micro grams per dose.
Effective August 9, 2020, the United States Department of Defense awarded MODERNATX INC. a contract for the large-scale production of up to 500 million doses of Moderna’s mRNA-1273, at 100 micro grams per dose.
